ACADIA PHARMACEUTICALS INC company info

CIK 1070494
IRS Number 061376651
State of incorporation DE
Business address 3611 VALLEY CENTRE DRIVE
SUITE 300
SAN DIEGO
CA
92130
Mail address 3611 VALLEY CENTRE DRIVE
SUITE 300
SAN DIEGO
CA
92130

Short summary

ACADIA PHARMACEUTICALS INC is a California company, with head office located at 3611 Valley Centre Drive San Diego, California 92130. In 2018 the company owned a total of 540.20 million USD worth of assets, including 526.11 million USD worth of current assets. The company amassed the most assets last year, totalling up to 540.20 million USD.

ACADIA PHARMACEUTICALS INC Income Statement

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Gross Profit 14.25115.82211.43
Selling, General and Administrative Expense 32.7588.30186.46255.06265.76
Research and development 41.5920.5817.3118.7926.7260.6073.8799.28149.19187.16
Operating Expenses 51.8727.0424.9225.7939.4493.35164.67
Operating Income (Loss) -45.4715.09-22.85-20.89-38.30-93.23-164.61-272.82-292.41-247.44
Income Tax Expense (Benefit) 0.010.020000.331.341.121.26
Net income -45.1515.14-22.77-20.85-37.95-92.48-164.44-271.39-289.40-245.19

ACADIA PHARMACEUTICALS INC Balance Sheet

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Cash and cash equivalents 21.178.818.029.2124.2513.7093.21131.77143.7974.18134.76
Available-for-sale Securities, Current 12.1483.03
Accounts Receivable, Net, Current 0.2911.5925.7026.09
Inventories 2.876.004.744.07
Property, Plant and Equipment, Gross 6.294.782.552.694.996.496.897.51
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 6.144.731.972.142.793.414.234.21
Intangible Assets, Net (Excluding Goodwill) 7.756.284.804.06
Other Assets, Noncurrent 0.090.010.060.110.331.110.523.191.90
Total assets 41.3121.87206.91359.47275.54438.03456.32314.96540.20
Current assets 41.0221.78206.76358.85273.39423.90443.75301.10526.11
Accounts payable 1.140.761.181.102.921.023.593.333.17
Total current liabilities 5.956.767.789.3419.3829.0240.9149.2159.57
Deferred Revenue, Noncurrent 2.482.41
Total liabilities 8.499.175.959.3619.7229.2241.1850.2461.12
Common Stock, Value, Issued 0.010.010.010.010.010.010.010.010.01
Retained Earnings (Accumulated Deficit) -336.50-358.51-382.92-444.99-577.90-783.67-1,089.55-1,341.23-1,468.86
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.010.00-0.030.090.010.21-0.10-0.50-0.37

ACADIA PHARMACEUTICALS INC Cash Flow

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Net income -45.1515.14-22.77-20.85-37.95-92.48-164.44-271.39-289.40-245.19
Depreciation and amortization 0.290.110.080.21
Depreciation 1.110.610.290.110.080.210.650.841.241.53
Amortization of Intangible Assets 000.991.481.48
Accounts receivable 5.9011.448.75
Inventories 3.311.01-1.93
Accounts payable 0.66-0.99-0.03-0.59-1.001.64-0.342.244.87-5.62
Deferred revenue 28.18-25.30-0.06-2.82-0.38-0.062.64-2.64
Net Cash Provided by (Used in) Operating Activities -13.73-10.70-19.90-21.63-208.41-217.76-167.47
Payments to Acquire Property, Plant, and Equipment 0.000.620.182.141.510.812.15
Payments to Acquire Intangible Assets 8
Net Cash Provided by (Used in) Investing Activities 9.44-1.065.98-25.53-261.9292.47-71.49
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 5.98-25.53-126.10-87.27147.57-261.9292.47
Proceeds from Issuance of Common Stock 1.920.8214.0298.20111.68203.8514.55518.9031.19306.65
Net Cash Provided by (Used in) Financing Activities 1.160.4713.9498.17533.8131.19306.65
Cash and Cash Equivalents, Period Increase (Decrease) -3.05-11.270.0451.01-46.1950.1540.2861.48-94.20